| Literature DB >> 23182089 |
Vikas Tyagi1, Shahnawaz Khan, Rahul Shivahare, Khushboo Srivastava, Suman Gupta, Saqib Kidwai, Kumkum Srivastava, S K Puri, Prem M S Chauhan.
Abstract
A natural product inspired molecular hybridization approach led us to a series of novel pentamidine based pyrimidine and chalcone scaffolds. All the hybrids were evaluated for their anti-leishmanial potential. Most of the screened compounds have showed significant in vitro anti-leishmanial activity with less cytotoxicity in comparison to the standard drugs (pentamidine, sodium stibogluconate, and miltefosine). Additionally, anti-malarial screening of these compounds was also done and four compounds have shown superior activity against chloroquine resistance strain (K1) of Plasmodium falciparum.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23182089 DOI: 10.1016/j.bmcl.2012.10.101
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823